tradingkey.logo

Recordati Signs Exclusive Licensing & Supply Agreement With Amarin To Commercialize Vazkepa In Europe

ReutersJun 24, 2025 11:09 AM

- Recordati Industria Chimica e Farmaceutica SpA RECI.MI:

  • RECORDATI ANNOUNCES EXCLUSIVE LICENSING & SUPPLY AGREEMENT WITH AMARIN TO COMMERCIALIZE VAZKEPA IN EUROPE

  • RECORDATI TO PAY AMARIN AN UPFRONT CASH PAYMENT OF US$ 25 MILLION

  • AMARIN TO SUPPLY FINISHED PRODUCT TO RECORDATI, IS ELIGIBLE TO RECEIVE ROYALTIES FOR SUPPLY OF PRODUCT UNDER TERMS OF AGREEMENT, COMMERCIAL MILESTONES UP TO TOTAL OF US$ 150 MILLION IF ANNUAL REVENUES FOR VAZKEPA® IN TERRITORIES IN SCOPE EXCEED CERTAIN SALES THRESHOLDS STARTING FROM € 100 MILLION

  • MORE DETAILS TO BE PROVIDED ON JULY 30

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI